Imatinib and Carvedilol for High Blood Pressure in the Lungs in Adults With Sickle Cell Disease

NCT01568645 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Pulmonary Hypertension

Interventions

DRUG: Carvedilol
DRUG: Imatinib

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)